Interesting insight. Thanks for sharing. Are those remuneration figures based on shares/options at current value or is it purely cash in the pocket??? I would guess that management are hurting as well? I'm also curious how much the new leadership are driving the share value down so that they can then secure greater options in future periods against a growing SP???
- Forums
- ASX - By Stock
- Director Remuneration
Interesting insight. Thanks for sharing. Are those remuneration...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add YOW (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.734M |
Open | High | Low | Value | Volume |
2.5¢ | 2.5¢ | 2.5¢ | $1K | 40K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46278 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 1309 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 46278 | 0.025 |
4 | 143494 | 0.023 |
1 | 45499 | 0.022 |
1 | 95383 | 0.021 |
1 | 250000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 1309 | 1 |
0.028 | 50000 | 2 |
0.030 | 38056 | 1 |
0.034 | 19500 | 1 |
0.036 | 333333 | 1 |
Last trade - 12.46pm 15/07/2024 (20 minute delay) ? |
Featured News
YOW (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online